Free tool
Oncology stocks
We cover 20 companies grouped under the Oncology theme. The median market value in the group is $545.42M. Across the group, the median move over the past trading day is +0.04%. Price change over the past year runs from −24.9% to +352.6% across the middle 80 percent of the group, with a median of +3.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
20 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% | Oct 29, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% | Oct 30, 2026 |
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +53.49% | Oct 27, 2026 |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% | Nov 5, 2026 |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +50.53% | Oct 27, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% | Sep 29, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% | Nov 12, 2026 |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% | Nov 12, 2026 |
| 0QAV.L | Nanobiotix S.A. | $671.98M | Small cap | +351.98% | Sep 29, 2026 |
| 0KCS.L | OPKO Health, Inc. | $578.38M | Small cap | +5.64% | Oct 28, 2026 |
| 0IL8.L | Kyntra Bio, Inc. | $512.46M | Small cap | −28.07% | Nov 9, 2026 |
| 0LOV.L | Verastem, Inc. | $470.33M | Small cap | −19.93% | Nov 3, 2026 |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% | Aug 27, 2026 |
| 0XOD.L | UroGen Pharma Ltd. | $347.24M | Small cap | +136.88% | Nov 5, 2026 |
| 0IV3.L | Geron Corporation | $255.34M | Small cap | +7.77% | Nov 4, 2026 |
| IDD.DE | Innate Pharma S.A. | $243.27M | Small cap | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% | Sep 17, 2026 |
| BINV.ST | BioInvent International AB (publ) | $162.35M | Small cap | −23.46% | Aug 27, 2026 |
| 0IMT.L | Photocure ASA | $144.18M | Small cap | −12.66% | Oct 28, 2026 |
| 0RU5.L | Oncoinvent ASA | $128.23M | Small cap | +7339.02% | Aug 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.